Your browser doesn't support javascript.
loading
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.
Kim, S T; Banks, K C; Pectasides, E; Kim, S Y; Kim, K; Lanman, R B; Talasaz, A; An, J; Choi, M G; Lee, J H; Sohn, T S; Bae, J M; Kim, S; Park, S H; Park, J O; Park, Y S; Lim, H Y; Kim, N K D; Park, W; Lee, H; Bass, A J; Kim, K; Kang, W K; Lee, J.
Afiliação
  • Kim ST; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Banks KC; Department of Medical Affair, Guardant Health, Dana-Farber Cancer Institute, Boston, USA.
  • Pectasides E; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Kim SY; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim K; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lanman RB; Department of Medical Affair, Guardant Health, Dana-Farber Cancer Institute, Boston, USA.
  • Talasaz A; Department of Medical Affair, Guardant Health, Dana-Farber Cancer Institute, Boston, USA.
  • An J; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Choi MG; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Lee JH; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Sohn TS; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Bae JM; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Kim S; Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Surgery, Samsung Medical Center, Seoul, Korea.
  • Park SH; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park JO; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park YS; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lim HY; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim NKD; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Park W; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Lee H; Sungkyunkwan University School of Medicine, Seoul, Korea; Division of Gastroenterolog, Department of Medicine, Samsung Medical Center, Seoul, Korea.
  • Bass AJ; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Kim K; Pathology and Translational Genomics, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang WK; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee J; Division of Hematology-Oncolog, Department of Medicine, Samsung Medical Center, Seoul, Korea; Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: jyunlee@skku.edu.
Ann Oncol ; 29(4): 1037-1048, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29409051
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Lapatinib / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Lapatinib / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article